ABOUT ISNR
Directors | Staff | Committee Chair Persons | Journal of Neurotherapy | Standards Policies | About ISNR | Disclaimers
DIRECTORS |
|||||
President, |
 |
|
|
||
Past President, |
 |
Treasurer, |
 |
||
Secretary, |
 |
Sergeant at Arms, |
 |
||
Member at Large, |
 |
Member at Large, |
 |
||
International Member at Large, Martijn Arns, MSc |
 |
||||
STAFF |
|||||
Executive Director, |
|
Membership and Conference Coordinator, |
 |
||
COMMITTEE CHAIRPERSONSExecutive Committee, Tom Collura, PhD JOURNAL OF NEUROTHERAPY: Investigations in Neuromodulation, Neurofeedback and Applied NeuroscienceSenior Editor, Journal of Neurotherapy, Martijn Arns, MSc Journal of Neurotherapy PAGE |
|||||
STANDARDS POLICY FOR SUBMISSION TO THE CONFERENCE (exhibiting and presenting) AND JOURNAL (articles)
Methods of application are:
1) submission for publication in the Journal of Neurotherapy,
2) submission for presentation at the annual ISNR conference or
3) application for exhibiting as a vendor at the annual ISNR conference
Any new therapeutic applications are welcome to expose themselves in the above 3 ways. However, within 2 years after the first exposure in any of these 3 ways they should have demonstrated either the working mechanism for the proposed application or have demonstrated a proof of clinical efficacy in line with "Level 3: Probably Efficacious" of the ISNR / AAPB guidelines for rating clinical efficacy (see below). It has to be noted that this should at least include data of 1 randomized controlled trial (RCT) using an adequate control group.
We understand that for many procedures it is hard and sometimes impossible to demonstrate the working mechanism. However, if any such treatment really has clinically meaningful effects it is not unrealistic to conduct at least 1 RCT, where patients are randomized to the active treatment and a control group (minimum requirement should be a waiting list control group). Sample sizes of say 20-30 patients should already be sufficient to demonstrate clinical efficacy.
This procedure will apply to both new applications but also to applications which have been disseminating information in the journal or at the conferences over the last couple of years, however the 2 years will start after this proposal has been formally accepted. ( July 11, 2010)
Level 1: Supported only by anecdotal reports and/or case studies in nonpeer reviewed venues. Not empirically supported.
Level 2: Possibly Efficacious. At least one study of sufficient statistical power with well identified outcome measures, but lacking randomized assignment to a control condition internal to the study.
Level 3: Probably Efficacious. Multiple observational studies, clinical studies, wait list controlled studies, and within-subject and intrasubject replication studies that demonstrate efficacy.
Level 4: Efficacious:
(a) In a comparison with a no-treatment control group, alternative treatment group, or sham (placebo) control utilizing randomized assignment, the investigational treatment is shown to be statistically significantly superior to the control condition or the investigational treatment is equivalent to a treatment of established efficacy in a study with sufficient power to detect moderate differences,
(b) The studies have been conducted with a population treated for a specific prob- lem, for whom inclusion criteria are delineated in a reliable, operationally defined manner,
(c) Thestudyusedvalidandclearlyspecifiedoutcomemeasuresrelatedtotheproblem being treated,
(d) The data are subjected to appropriate data analysis,
(e) The diagnostic and treatment variables and procedures are clearly defined in amanner that permits replication of the study by independent researchers, and (f) The superiority or equivalence of the investigational treatment have been shown in at least two independent research settings.
Level 5: Efficacious and Specific. The investigational treatment has been shown to be statistically superior to credible sham therapy, pill, or alternative bona fide treatment in at least two independent research settings.
About ISNR
The International Society for Neurofeedback & Research (ISNR) is a membership organization comprised of people from many countries and various professional disciplines doing neurotherapy, neurofeedback training and research. ISNR supports education and excellence in the field of neurofeedback training and neurotherapy and seeks the validation and acceptance of this discipline by a broad spectrum of society.
Both the society and its members gladly cooperate with other like-minded organizations and individuals. Today, neurofeedback, also called EEG biofeedback or EEG operant conditioning, is the most commonly used form of neuronal regulation. It is often used in conjunction with other forms of biofeedback as well as with whatever other professional services its practitioners are additionally qualified and licensed to render such as, psychology, medicine, clinical social work, nursing, education, counseling, etc. Persons who fit within this framework are cordially invited to submit an application for membership.
Quantitative EEG (QEEG) or brain mapping is commonly used to guide the most efficient application of neurofeedback.
The original name of the society from 1995 through 1998 was, Society for the Study of Neuronal Regulation, but it was shortened to Society for Neuronal Regulation for simplicity and to better convey the purposes of the organization. The name was changed again in 2002 to International Society for Neuronal Regulation and again in 2006 to International Society for Neurofeedback & Research to better reflect the fact that members of the society now came from all parts of the globe, not just North America and that research is a critical function of the society.
ISNR members, prospective members, and the public are invited to review the. . . Articles of Incorporation and ISNR Bylaws.
DISCLAIMERS
- The International Society for Neurofeedback & Research (ISNR) is providing all contents and materials within its own web site as a public informational service only.
- ISNR makes absolutely no endorsement of any statement made in any of the internal materials provided within this site nor of any statement made in any materials obtained from external links listed at this site.
- The Board of Directors of ISNR wishes to clarify that ISNR has no association whatsoever with any EEG biofeedback or neurofeedback certifying organization. ISNR is a membership organization which draws its members from fields of medicine, psychology, psychophysiology, counceling, social work, nursing, education and other related fields.